Filter News
Area of Research
- (-) Nuclear Science and Technology (6)
- Advanced Manufacturing (4)
- Biological Systems (1)
- Biology and Environment (9)
- Clean Energy (36)
- Climate and Environmental Systems (1)
- Computational Engineering (1)
- Computer Science (10)
- Fusion Energy (4)
- Isotopes (1)
- Materials (73)
- Materials for Computing (3)
- National Security (11)
- Neutron Science (22)
- Quantum information Science (6)
- Sensors and Controls (1)
- Supercomputing (62)
- Transportation Systems (1)
News Type
News Topics
- (-) Biomedical (2)
- (-) Computer Science (2)
- (-) Materials Science (2)
- 3-D Printing/Advanced Manufacturing (4)
- Advanced Reactors (11)
- Bioenergy (1)
- Coronavirus (1)
- Cybersecurity (1)
- Decarbonization (1)
- Environment (1)
- Fusion (7)
- Isotopes (5)
- Molten Salt (4)
- Neutron Science (4)
- Nuclear Energy (31)
- Physics (1)
- Space Exploration (4)
- Sustainable Energy (1)
- Transformational Challenge Reactor (3)
Media Contacts
Oak Ridge National Laboratory researchers have discovered a better way to separate actinium-227, a rare isotope essential for an FDA-approved cancer treatment.
Scientists at the Department of Energy Manufacturing Demonstration Facility at ORNL have their eyes on the prize: the Transformational Challenge Reactor, or TCR, a microreactor built using 3D printing and other new approaches that will be up and running by 2023.
With Tennessee schools online for the rest of the school year, researchers at ORNL are making remote learning more engaging by “Zooming” into virtual classrooms to tell students about their science and their work at a national laboratory.
The Department of Energy’s Oak Ridge National Laboratory is collaborating with industry on six new projects focused on advancing commercial nuclear energy technologies that offer potential improvements to current nuclear reactors and move new reactor designs closer to deployment.
A tiny vial of gray powder produced at the Department of Energy’s Oak Ridge National Laboratory is the backbone of a new experiment to study the intense magnetic fields created in nuclear collisions.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.